Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
139.58
-4.26 (-2.96%)
Mar 9, 2026, 3:30 PM IST
-10.01% (1Y)
| Market Cap | 2.65B |
| Revenue (ttm) | 4.46B |
| Net Income (ttm) | 431.20M |
| Shares Out | 19.00M |
| EPS (ttm) | 22.69 |
| PE Ratio | 6.15 |
| Forward PE | n/a |
| Dividend | 2.00 (1.39%) |
| Ex-Dividend Date | Aug 14, 2025 |
| Volume | 16,947 |
| Average Volume | 16,354 |
| Open | 143.10 |
| Previous Close | 143.84 |
| Day's Range | 138.00 - 144.20 |
| 52-Week Range | 136.00 - 238.69 |
| Beta | 0.51 |
| RSI | 44.21 |
| Earnings Date | Apr 24, 2026 |